Abstract:Importance Neural tube defects are among the most common birth defects in the US. Objective To review new evidence on the benefits and harms of folic acid supplementation for the prevention of neural tube defects to inform the US Preventive Services Task Force. Evidence Review Sources included PubMed, Cochrane Library, Embase, and trial registries from July 1, 2015, through July 2, 2021; references; and experts, with surveillance through February 10, 2023. Two investigators independently reviewed English-language randomized studies and nonrandomized cohort studies in very highly developed countries that focused on the use of folic acid supplementation for the prevention of neural tube defect-affected pregnancies; methodological quality was dually and independently assessed. Findings Twelve observational studies (reported in 13 publications) were eligible for this limited update (N = 1 244 072). Of these, 3 studies (n = 990 372) reported on the effect of folic acid supplementation on neural tube defects. For harms, 9 studies were eligible: 1 randomized clinical trial (n = 431) reported on variations in twin delivery, 7 observational studies (n = 761 125) reported on the incidence of autism spectrum disorder, and 1 observational study (n = 429 004) reported on maternal cancer. Two cohort studies and 1 case-control study newly identified in this update reported on the association between folic acid supplementation and neural tube defects (n = 990 372). One cohort study reported a statistically significant reduced risk of neural tube defects associated with folic acid supplementation taken before pregnancy (adjusted relative risk [aRR], 0.54 [95% CI, 0.31-0.91]), during pregnancy (aRR, 0.62 [95% CI, 0.39-0.97]), and before and during pregnancy (aRR, 0.49 [95% CI, 0.29-0.83]), but this association occurred for only the later of 2 periods studied (2006-2013 and not 1999-2005). No other statistically significant benefits were reported overall. No study reported statistically significant harms (multiple gestation, autism, and maternal cancer) associated with pregnancy-related folic acid exposure. Conclusions and Relevance New evidence from observational studies provided additional evidence of the benefit of folic acid supplementation for preventing neural tube defects and no evidence of harms related to multiple gestation, autism, or maternal cancer. The new evidence was consistent with previously reviewed evidence on benefits and harms.

Trends in neural tube defects in Scotland 2000-2021 prior to the introduction of mandatory folic acid fortification of non-wholemeal wheat flour: a population-based study.

Effects of Folic Acid Supplementation During Different Pregnancy Periods and Relationship with the Other Primary Prevention Measures to Neural Tube Defects

Maternal body mass index and the association between folic acid supplements and neural tube defects.

Neural tube defects prevalence does not increase after modification of the folic acid fortification program in Chile

Status of Prevention of Neural Tube Defects Post-Folic Acid Fortification of Cereal Grains in South Africa

A global update on the status of prevention of folic acid‐preventable spina bifida and anencephaly in year 2020: 30‐Year anniversary of gaining knowledge about folic acid's prevention potential for neural tube defects

Folic Acid Fortification and Neural Tube Defect Risk: Analysis of the Food Fortification Initiative Dataset

Folate fortification for spina bifida: preventing neural tube defects

Nutrition, One-Carbon Metabolism and Neural Tube Defects: A Review

Modeling the impact of folic acid fortification and supplementation on red blood cell folate concentrations and predicted neural tube defect risk in the United States: have we reached optimal prevention?

Prevalence of Neural Tube Defects Following Flour Fortification with Folic Acid in North Iran

Folate and vitamin B12 status and predicted neural tube defects risk among nonpregnant women of reproductive age from the Malawi National Micronutrient Survey, 2015–2016

OC126: the PONTI (prevention of Neural Tube Defects by Inositol) Clinical Trial

Periconceptional folic acid and risk for neural tube defects among higher risk pregnancies.

Blood folate level needed for fully effective neural tube defect prevention

Prevention of Neural Tube Defects with Folic Acid: the Chinese Experience.

Risk factors for neural-tube defects detected in utero: A prospective community-based study from Addis Ababa

High Ratios Of C20:4n-6/C20:5n-3 And Thromboxane B-2/6-Keto-Prostaglandin F-1 Alpha In Placenta Are Potential Risk Contributors For Neural Tube Defects: A Case-Control Study In Shanxi Province, China

High Ratios of C20:4n-6/C20:5n-3 and Thromboxane B2 /6-Keto-prostaglandin F1α in Placenta Are Potential Risk Contributors for Neural Tube Defects: A Case-Control Study in Shanxi Province, China.

Pre-conception folic acid and multivitamin supplementation for the prevention of Neural Tube Defect: An umbrella Review

Folic Acid Supplementation to Prevent Neural Tube Defects: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.